Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan-Reference-Cited by-同舟云学术

Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan

Author:

Nangaku Masaomi¹,Kondo Kazuoki²,Takabe Souichirou²^ORCID,Ueta Kiichiro²,Kaneko Genki²,Otsuka Makiko²,Kawaguchi Yutaka²,Komatsu Yasuhiro³

Affiliation:

1. Graduate School of Medicine, The University of Tokyo Tokyo Japan

2. Integrated Value Development Division, Medical Intelligence Department Mitsubishi Tanabe Pharma Corporation Tokyo Japan

3. Graduate School of Medicine, Gunma University Maebashi Gunma Japan

Funder

Mitsubishi Tanabe Pharma Corporation

Publisher

Wiley

Subject

Nephrology,Hematology

Link

Reference39 articles.

2. Anemia in patients with chronic kidney disease: Current screening and management approaches;Rivera R;Nephrol Renal Dis,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Management of Anemia in Peritoneal Dialysis Patients;Nolph and Gokal's Textbook of Peritoneal Dialysis;2023